Results 261 to 270 of about 106,373 (291)

[Detection and interpretation of PD-L1 in urologic neoplasms].

Zhonghua bing li xue za zhi = Chinese journal of pathology
Immune checkpoint inhibitors targeting PD-1/PD-L1 are gradually being applied in the treatment of advanced urinary system tumors. Immunohistochemical analysis of PD-L1 expression is the most popular method for screening suitable patients for immunotherapy and predicting therapeutic efficacy. The current application status of PD-L1 detection for urinary
M Z, Gong, H Y, He
openaire   +1 more source

Aspiration Cytology in the Staging of Urological Neoplasms

European Urology, 1985
openaire   +2 more sources

[Tumor markers in urologic neoplasms].

Fortschritte der Medizin, 1986
M, Wirth, J W, Grups, H, Frohmüller
openaire   +1 more source

[Treatment of urologic neoplasms with interferon].

Khirurgiia, 1990
Kh, Kumanov, M, Tsvetkov, K, Neĭkov
openaire   +1 more source

Authors' Reply: Sexual Rehabilitation of Urologic Cancer Patients

Ca-A Cancer Journal for Clinicians, 1985
Leslie Schover, A C von Eschenbach
exaly  

[X-ray diagnosis of urologic neoplasms: bladder neoplasms].

Zeitschrift fur Urologie und Nephrologie, 1979
E, Baudisch, C, Schleicher, I, Marzoll
openaire   +1 more source

Aspiration Cytology in the Staging of Urological Neoplasms

Urologia Journal, 1984
openaire   +1 more source

Malignant neoplasms associated with human immunodeficiency virus infection

Ca-A Cancer Journal for Clinicians, 1992
B Safai
exaly  

Urinary Lactic Acid Dehydrogenase Activity in the Diagnosis of Urologic Neoplasms

Journal of Urology, 1966
D A, Lee, A T, Cockett, B M, Caplan, N, Chiamori   +3 more
openaire   +2 more sources

Cell Differentiation and the Development of Colonic Neoplasms

Ca-A Cancer Journal for Clinicians, 1970
M Lipkin
exaly